to complete a questionnaire about sociodemographic factors, medical history, and risk factors for 1 cancer. Usual dietary intake over the 12 months prior to enrollment was assessed with a 137-item 2 food frequency questionnaire including 14 additional questions about intake of vitamin and 3 mineral supplements and 10 additional questions on meat cooking practices (12) . Daily dietary 4 nutrient intake was calculated by multiplying the daily frequency of each consumed food item by 5 the nutrient value of the sex-specific portion size, using the nutrient database from the U.S. 6 Department of Agriculture (13) . Total vitamin and mineral intakes were calculated using the sum 7 of dietary and supplement intakes. 8
Laboratory Analysis. Nonfasting blood specimens collected at the clinical centers were 9 processed and frozen within 2 hours of blood draw and stored at -70ºC. Serum concentrations of 10 total retinol (bound and unbound) were determined using reversed-phase high-performance 11 liquid chromatography, with UV detection (14) . Cases and their matched controls were analyzed 12 in the same batch. Blinded quality control samples were randomly inserted into each batch. The 13 coefficient of variation estimated from 171 blinded duplicates was 5.1%. To investigate the 14 reproducibility of serum retinol concentrations over time we also included a second serum 15 sample drawn 1 year after study entry in the same sample batch as the subject-paired serum 16 sample collected at study entry for a subset of 46 controls. Serum concentrations of selenium and 17 cholesterol were measured for another nested case-control study, and the methods have been 18 described previously (15 calcium, serum selenium, serum cholesterol, month of blood draw); however, none were 8 included in the analyses because the factors, either separately or together, did not change the risk 9
estimates by more than 10%. To assess effect modification we performed stratified analyses and 10 evaluated the statistical significance of multiplicative interaction terms by comparing the -2 log-11 likelihood statistics of the main effect model and the model including the interaction term. 12
Spearman correlation coefficients were calculated to measure the correlation between serum 13 retinol concentrations obtained one year apart in 46 controls and between serum concentrations 14 and dietary vitamin A intake in all controls. Correlation coefficients were adjusted for month of 15 blood draw, serum cholesterol concentration, smoking, body mass index, age, and energy intake. 16 All P values are two-sided and significance set at the 0.05 level. 17
RESULTS

18
The distribution, overall and by retinol concentrations, of demographic and health-related 19 covariates possibly linked to prostate cancer risk is shown in Table 1 . The average age at study 20 entry among controls was 64.7 years and did not vary by retinol concentration. Compliance with 21 the PLCO screening protocol was very high and did not differ by serum retinol concentrations, as 22
shown by the average number of cancer screens (PSA or DRE; Table 1 ). Men with higher serum 23 Schenk, et al. pg 9 of 16 retinol concentrations were less likely to have a personal history of diabetes, and had higher 1 serum cholesterol concentrations, were less obese, more likely to smoke, more physically active 2 and more likely to use aspirin. Men with higher serum retinol concentrations also had a lower 3 intake of fat and red meat, and higher intakes of PhIP, vitamin D, supplemental vitamin E, and 4 alcohol. The average time between blood collection and prostate cancer diagnosis (among cases) 5 was 2.4 + 1.4 years. The correlation between serum retinol concentrations measured in 46 men 6 at study entry and 1 year later was modest (r=0.38; p=0.009), and the correlation between serum 7 retinol and vitamin A intake from diet and supplements among controls was weak (r=0.08, 8 p=0.06). 9
Median serum retinol concentrations did not differ significantly between cases and controls 10 (67.11 versus 68.52 ug/dl, p=0.22). In multivariate analyses comparing men in the highest to 11 lowest quintiles, serum retinol was associated with a non-significant 20% reduction in risk of 12 prostate cancer with no indication of a linear trend (P trend 0.11, Table 2 Study, high retinol concentrations were associated with a decreased risk of prostate cancer(8) and 14 in CLUE I a non-significant inverse association between serum retinol and prostate cancer was 15 reported(9), although this finding was not confirmed on further follow-up (6) . 16 Analyses in many of these studies were limited to total prostate cancer, and therefore, 17 differences in associations according to stage or grade of disease may have been obscured(2, 4-6, 18 8, 9). For prostate cancer, this is particularly important since the disease is heterogeneous and 19 the significance of early-stage (PSA-detected) disease is unclear (16) . Two larger prospective 20 studies (n=578 and n=966 cases) analyzed non-aggressive and aggressive cancers separately, 21 although neither found an association between retinol concentrations and risk of aggressive 22 Schenk, et al. pg 11 of 16 (Stage III or IV or Gleason sum>7)(7) or advanced (T3 or T4, N1+, M1 or metastatic)(3) 1 disease, and one reported an elevated risk for high levels of retinol that was limited to non-2 aggressive(Stage I or II and Gleason sum<7) disease(7). In the current study, the association of a 3 decreased risk with increasing retinol concentrations was limited to aggressive disease and was 4 strongest for high-grade disease. This association did not differ by year of diagnosis (<4 versus 5 > 4), suggesting that a reverse-causality effect on retinol is unlikely. These findings could 6
indicate that retinol has a specific effect on disease progression(17), although it is also possible 7 that this association is due to chance as our study is the only one reporting an inverse association 8 with aggressive disease specifically. 9
Our findings are supported by several in vitro and animal models which demonstrate a 10 key role for retinol in regulating the growth, differentiation and apoptosis of normal and 11 malignant prostate cells (18, 19) . In experimental models, retinoids suppress transforming effects 12 of carcinogens, inhibit growth of premalignant cells, enhance differentiation of malignant cells 13 and induce apoptosis (20) . These regulatory effects are mediated through the activation of two 14 families of retinoid nuclear receptors, retinoic acid receptors (RARs) and retinoid X receptors 15 (RXRs). Prostate cancer tissue has lower levels of retinoic acid (21) , and low retinol levels could 16 also directly alter the expression of retinoic acid and retinoid X receptors (22) , which have been 17
shown to be selectively reduced in prostate cancers (23) . 18 It is unlikely these findings can be solely attributed to differences in dietary or 19 supplemental retinol intake, given that serum retinol concentrations are under tight homeostatic 20 control(24), and neither dietary intake nor supplements is strongly correlated with retinol 21 concentrations (25, 26) . However, it should be noted that the range of retinol concentration in 22 this study population is wide (27.4 to 262.6 ug/dl), and other factors such as BMI, physical 23 pg 12 of 16 activity, and dietary fat and alcohol intake are correlated with retinol concentrations, suggesting 1 that in a well-nourished population, these factors influence retinol concentrations to some degree. 2
Lower concentrations of retinol may reflect insufficient vitamin A stores in the liver, although 3 this is unlikely given the healthy study population. Alternatively, low circulating retinol 4 concentrations could result from underlying aberrations in cellular retinol binding protein 5 (CRBP) metabolism (27) . CRBP plays an essential role in the maintenance of hepatic retinol 6 stores and the synthesis of retinoic acid from retinol (24) , and the reduction or loss of CRBP1 7 expression has been demonstrated in prostate carcinomas (28) . 8
A limitation of this study and previous observational studies is the use of a single baseline 9 measure of serum retinol. Although one examination of the repeatability of serum retinol 10 concentrations 15 years apart showed moderate correlation (r=0.58; 95%CI:0.46-0.67) (29) ; the 11 correlation between serum retinol concentrations 1 year apart in this study was somewhat lower 12 (r=0.38; p=0.009) and thus, a single measure of serum retinol may not be representative of long-13 term retinol exposure. Nonetheless, such non-differential measurement error in serum retinol 14 generally leads to an attenuation of the estimated association, and the true protective effect 15 should be stronger than that found in our study. A further limitation is the relatively short follow-16 up of 8 years. 17
The strengths of this study include standardized procedures for prostate cancer screening 18 and very high compliance with the screening protocol, availability of pre-diagnostic serum 19 samples, a large sample size, and detailed diagnostic data which allowed stratification by stage 20 and grade and simultaneous adjustment for multiple confounders. 21
In summary, our results support a protective association between serum retinol 22 concentrations and risk of aggressive prostate cancer. Further research to better understand the 23 3 Aggressive defined as Gleason Sum ≥7 or stage III or IV 4 Adjusted for age, time since initial screening, year of blood draw, and study center
